Medical Device Network on MSN

NG Biotech announces FDA approval for diagnostic assays

NG Biotech manufactured the assays in France, with Hardy Diagnostics serving as the exclusive distributor in the US.

FDA Grants Breakthrough Device Designation to Two Rapid Tests Targeting Critical Drug-Resistant Pathogens

In a major step forward against Antimicrobial Resistance (AMR), NG Biotech, in partnership with Hardy Diagnostics, announced today that the U.S. Food and Drug Administration (FDA) has granted ...
IEEE

A Rapid, Pulsed Laser Testing Approach for Single Event Latch-Up Screening

Abstract: Sandia National Laboratories (SNL) has developed a custom pulsed laser single event effects testing facility utilizing a tunable wavelength (680–1080 nm), 140 fs, 80 MHz, Ti:sapphire laser.